Nima E. is currently an Analyst at EcoR1 Capital, LLC, starting in 2024, and has served as Chairman and Co-Founder of Avail Bio since 2019. Avail Bio is a venture-backed immunology biotech focused on developing therapies for immunologic diseases using a novel immunoproteomic single cell platform, supported by notable investors such as Viking Global Investors and Illumina Accelerator. Nima E. holds a Doctor of Philosophy (PhD) in Biological and Medical Informatics from the University of California, San Francisco, and a Bachelor of Science (BS) in Bioengineering and Electrical Engineering and Computer Science from the University of California, Berkeley. Additionally, Nima E. has completed the AI Professional Program in Artificial Intelligence at Stanford University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices